CHENGDU, China, Dec. 23, 2024 /PRNewswire/ — Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the “NMPA”) of China has recently approved the supplemental New Drug Application (the “sNDA”) of Stapokibart (anti-IL-4Rα monoclonal antibody,…
Tag: PR Newswire
PHILADELPHIA, 23 de diciembre de 2024 /PRNewswire-HISPANIC PR WIRE/ — El Abogado del grupo emite la siguiente declaración en relación con una demanda colectiva contra CoreCivic, Inc. ¿De qué trata este aviso? Actualmente, existe una demanda colectiva pendiente en relación a personas que…
PHILADELPHIA, Dec. 23, 2024 /PRNewswire/ — The following statement is being issued by Class Counsel regarding a class action lawsuit against CoreCivic, Inc. What Is This Notice About? A class action lawsuit is currently pending concerning detainees that were detained in the custody of…
ARLINGTON, Va., Dec. 23, 2024 /PRNewswire/ — The Consumer Technology Association (CTA)® welcomes Linda Yaccarino, CEO, X Corp, the world’s largest online news and social networking site, as a keynote speaker at CES® 2025. Yaccarino will join Emmy Award-winning investigative journalist…
PHILADELPHIA, Dec. 23, 2024 /PRNewswire/ — A pain management clinical practice guideline developed by Penn Dental Medicine’s Center for Integrative Global Oral Health (CIGOH) is among The Journal of the American Dental Association (JADA)’s top five trending articles for 2024, according…
First Available on Smart TVs, New Experiential and Interactive Music Service Brings A Fresh Approach to Karaoke at Home LOS ANGELES, Dec. 23, 2024 /PRNewswire/ — Cineverse (NASDAQ: CNVS), a next-gen entertainment studio, today announces the launch of an innovative, new connected TV app…
Die Nachhaltigkeitsstrategie von Miral umreißt wichtige Initiativen zur Erreichung des Ziels von Miral, bis zum Jahr 2030 zum Maßstab für die Nachhaltigkeit von LET in der Region zu werden Die Strategie stützt sich auf das anhaltende Engagement für verantwortungsvolle Unterhaltung. Die…
CHENGDU, China, Dec. 23, 2024 /PRNewswire/ — Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the “NMPA”) of China has recently approved the supplemental New Drug Application (the “sNDA”) of Stapokibart (anti-IL-4Rα monoclonal antibody,…
Company Launches ION Marketplace for Application Developers and Integration Partners LOS ANGELES, Dec. 23, 2024 /PRNewswire/ — First Resonance, a leader in digital manufacturing solutions, announced the successful close of its latest funding round, led by Third Prime, with support from…
SAN DIEGO, Dec. 23, 2024 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Celsius Holdings, Inc. (NASDAQ: CELH) common stock between February 29, 2024 and September 4, 2024, both dates inclusive (the “Class Period”), have until Tuesday, January…
